您的位置: 首页 > 农业专利 > 详情页

ANTICORPS MONOCLONAUX ANTI-IGF-1R ET UTILISATIONS DE CEUX-CI
专利权人:
FUSION PHARMACEUTICALS INC.;BURAK, ERIC STEVEN
发明人:
BURAK, ERIC STEVEN,FORBES, JOHN RICHARD,MORAN, MATTHEW DAVID BURR,SIMMS, RYAN WAYNE,VALLIANT, JOHN FITZMAURICE,DARWISH, ALLA
申请号:
CA3062538
公开号:
CA3062538A1
申请日:
2018.05.04
申请国别(地区):
CA
年份:
2018
代理人:
摘要:
The present invention relates to conjugates including a chelating moiety of ametal complex thereof and a therapeuticor targeting moiety, methods for their production, and uses thereof. Thepresent invention is directed to monoclonal antibodies thattarget the insulin-like growth factor-1 receptor and the radioimmunoconjugatesthereof that demonstrate increased potency and enhancethe excretion of a chelating moiety, or a metal complex thereof, whenconjugated to a therapeutic moiety, a targeting moiety, or across-linking group. In another aspect, the invention features apharmaceutical composition comprising a compound of the invention;and a pharmaceutically acceptable excipient. In another aspect, the inventionfeatures a method of radiation treatment planningand/or radiation treatment, the method comprising administering to a subjectin need thereof a compound or pharmaceutical compositionof the invention.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充